← Back to Search

Caffeine Reduction Manual for Caffeine Withdrawal

N/A
Waitlist Available
Led By Mary M Sweeney, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, at the time of intervention visit (within 1-2 weeks of screening), at 7 weeks post-intervention visit, at 14 weeks post-intervention visit
Awards & highlights

Study Summary

This trial will test whether a caffeine reduction program can help people cut back on their intake, and whether it's feasible to do it online.

Eligible Conditions
  • Caffeine Withdrawal
  • Gastrointestinal Dysfunction
  • Anxiety Disorder
  • Anxiety
  • Sleep Disorders
  • Diarrhea
  • Caffeine
  • Caffeine Addiction
  • Heartburn
  • Sleep Disorder
  • Insomnia
  • Anxiety Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, at the time of intervention visit (within 1-2 weeks of screening), at 7 weeks post-intervention visit, at 14 weeks post-intervention visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, at the time of intervention visit (within 1-2 weeks of screening), at 7 weeks post-intervention visit, at 14 weeks post-intervention visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment acceptability as assessed by treatment acceptability questionnaire
Treatment adherence as assessed by percentage of completed assessments
Secondary outcome measures
Anxiety
Change in anxiety as assessed by the PROMIS-Anxiety-8a
Change in caffeine consumption (in milligrams)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Caffeine Reduction Manual, Immediate Treatment GroupExperimental Treatment1 Intervention
Weekly caffeine consumption is to be measured before and after using the caffeine reduction program, which has been summarized in a "Guide to Caffeine Reduction and Cessation" manual to help people reduce their caffeine use. Those in the immediate treatment group will receive the guide immediately after screening.
Group II: Caffeine Reduction Manual, Delayed Treatment GroupExperimental Treatment1 Intervention
Weekly caffeine consumption is to be measured before and after using the caffeine reduction program, which has been summarized in a "Guide to Caffeine Reduction and Cessation" manual to help people reduce their caffeine use. Those in the delayed treatment group will receive the guide seven weeks after screening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Caffeine Reduction Manual
2020
N/A
~110

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,484 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,819,962 Total Patients Enrolled
Mary M Sweeney, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
2 Total Patients Enrolled

Media Library

Caffeine Reduction Manual Clinical Trial Eligibility Overview. Trial Name: NCT04560595 — N/A
Caffeine Withdrawal Research Study Groups: Caffeine Reduction Manual, Delayed Treatment Group, Caffeine Reduction Manual, Immediate Treatment Group
Caffeine Withdrawal Clinical Trial 2023: Caffeine Reduction Manual Highlights & Side Effects. Trial Name: NCT04560595 — N/A
Caffeine Reduction Manual 2023 Treatment Timeline for Medical Study. Trial Name: NCT04560595 — N/A
Caffeine Withdrawal Patient Testimony for trial: Trial Name: NCT04560595 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current intake capacity of this clinical trial?

"Affirmative, the information on clinicaltrials.gov implies that this medical experiment is currently trying to add participants. This trial was originally published on September 10th 2020 and recently modified March 15th 2022. A total of 100 individuals need to be recruited from one centre."

Answered by AI

What is the eligibility criteria for participation in this research endeavor?

"This clinical trial is looking to include a total of 100 participants, aged between 18 and 75. To be considered for this study, patients must also present with symptoms of diarrhea."

Answered by AI

Are there any available slots left in this clinical trial?

"According to the clinicaltrials.gov listing, this experiment is now open for recruitment and began on September 10th 2020 with its most recent update taking place on March 15th 2022."

Answered by AI

Are any individuals aged 55 or above being included in this trial?

"As stated in the inclusion criteria, patients aged 18 to 75 can partake in this clinical trial. Interestingly, there are 439 studies dedicated to those under 18 and 1269 for individuals over 65 years of age."

Answered by AI

What are the primary goals of this experiment?

"The primary outcome of this clinical trial, measured at 7 weeks post-intervention visit, is to evaluate adherence with the treatment. Secondary goals include gauging any changes in caffeine consumption (in milligrams), anxiety levels as assessed through GAD-7 scores, and sleep problems via Insomnia Severity Index results."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
Texas
Pennsylvania
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
1
What site did they apply to?
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center

Why did patients apply to this trial?

i like to reduce my dependency on caffine. Definitely need to reduce my caffeine intake it’s very low unhealthy.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Remote Guided Caffeine Reduction
2020. "Remote Guided Caffeine Reduction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04560595.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top